📢Meng Zhou and colleagues propose a deep learning framework with real-world pharmacovigilance data to predict population-scale toxicity profiles of checkpoint inhibitor immunotherapy, enabling timely tailoring of treatment. https://www.nature.com/articles/s43588-024-00748-8?utm_source=bluesky&utm_medium=social&utm_campaign=natcomputsci

🔓https://rdcu.be/d4Ao4

Comments